This invention relates to methods for treating cell proliferative diseases and conditions and ophthalmic diseases, disorders and conditions using compounds that inhibit protein tyrosine kinase activity. In particular the invention relates to the methods of treatment which utilize compounds that inhibit the protein tyrosine kinase activity of growth factor receptors, resulting in the inhibition of receptor signaling, for example, the inhibition of VEGF receptor signaling.
本发明涉及使用抑制
蛋白酪氨酸激酶活性的化合物治疗细胞增殖性疾病和病况以及眼科疾病、障碍和病况的方法。特别地,本发明涉及使用抑制生长因子受体
蛋白酪氨酸激酶活性的化合物的治疗方法,从而抑制受体信号传导,例如抑制V
EGF受体信号传导。